| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Weight Loss Articles
Company Says It Is the First to Identify the Gene
A gene said to cause obesity in humans has reportedly been discovered, according to an October 29, 2002, news release from Myriad Genetics, Inc., a company based in Salt Lake City, Utah.
The gene, called Human Obesity 1 (HOB1) in recognition of its direct causal tie to obesity, also "appears to provide an important molecular link between obesity and diabetes," the company claims, adding that the discovery of HOB1 is a "necessary first step" toward the development of a therapeutic treatment for obesity.
Myriad speculates that the HOB1 gene is likely to be vulnerable to drug therapy that would block the gene function, noting that "it is generally far easier to block a drug target than to replace its lost function."
The news release did not indicate a time line for developing a pharmaceutical agent to block HOB1.
Categories: Weight Loss
Feb 1, 2003 -
Email to a Friend
Send a link to this page to your friends and colleagues.